表紙
市場調查報告書

鼻腔給藥技術的全球市場:產業分析,市場規模·佔有率·成長率·趨勢·未來預測

Global Nasal Drug Delivery Technology Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2018 to 2025

出版商 Value Market Research 商品編碼 838485
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
鼻腔給藥技術的全球市場:產業分析,市場規模·佔有率·成長率·趨勢·未來預測 Global Nasal Drug Delivery Technology Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2018 to 2025
出版日期: 2019年03月01日內容資訊: 英文
簡介

本報告提供全球鼻腔給藥技術的市場相關分析,彙整技術·產品概要和市場基本結構,主要的推動及阻礙市場要素,整體市場趨勢預測 (今後8年份),不同形狀·容器別·治療各目的·各地區的詳細趨勢,市場競爭環境,主要企業簡介等調查。

第1章 簡介

第2章 摘要整理

第3章 市場分析

  • 簡介
  • 價值鏈分析
  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 波特的五力分析

第4章 鼻腔給藥技術市場分析:不同形狀

  • 噴霧 (噴霧材)
  • 滴液
  • 凝膠
  • 粉 (粉末)

第5章 鼻腔給藥技術市場分析:容器類別

  • 加壓容器
  • 非加壓容器

第6章 鼻腔給藥技術市場分析:各治療用途

  • 鼻子堵塞 (鼻塞)
  • 鼻炎
  • 氣喘
  • 其他

第7章 鼻腔給藥技術市場分析:各地區

  • 北美市場 (美國,加拿大等)
    • 市場規模的估計價值
    • 市場規模的估計價值:各國
  • 歐洲市場 (英國,德國,法國等)
  • 亞太地區市場 (中國,日本,印度等)
  • 南美市場 (巴西等)
  • 中東·非洲市場

第8章 鼻腔給藥技術企業:競爭環境

  • 市場競爭
  • 事業聯盟/合作,協定
  • 企業合併·收購 (M&A)
  • 新產品的銷售
  • 其他動向

第9章 鼻腔給藥技術產業:企業簡介 (企業概要,財務分析,主要產品,近幾年趨勢)

  • AstraZeneca
  • B.F. Ascher & Company, Inc.
  • Becton, Dickson and Company
  • Cadila Pharmaceuticals
  • Douglas NZ
  • ENT Technologies Pty. Ltd.
  • GlaxoSmithkline plc.
  • NAVEH Pharma
  • OptiNose
  • Pendopharm
  • Pfizer, Inc.
  • Promius Pharma
  • Tentative TOC
目錄

The report on Global Nasal Drug Delivery Technology Market evaluates the growth trends of the industry through historical study and estimates future prospects based on comprehensive research. The report extensively provides the market share, growth, trends and forecasts for the period 2018-2025. The market size in terms of revenue (USD MN) is calculated for the study period along with the details of the factors affecting the market growth (drivers and restraints).

  • Drivers
    • Growing adoption of self-administration practices
    • Increasing disposable income across the globe
    • Increasing focus on the alternative route for real drug delivery
  • Restraints
    • side effects such as nausea, irritation, and infections

Furthermore, the report quantifies the market share held by the major players of the industry and provides an in-depth view of the competitive landscape. This market is classified into different segments with detailed analysis of each with respect to geography for the study period:

  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Till: 2025

The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved. The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.

The report classifies the market into different segments based on forms, container type, and therapeutic application. These segments are studied in detail incorporating the market estimates and forecasts at regional and country level. The segment analysis is useful in understanding the growth areas and probable opportunities of the market.

The report also covers the complete competitive landscape of the worldwide market with company profiles of key players such as AstraZeneca, B.F. Ascher & Company, Inc., Becton, Dickson and Company, Cadila Pharmaceuticals, Douglas NZ, ENT Technologies Pty. Ltd., GlaxoSmithkline plc., NAVEH Pharma, OptiNose, Pendopharm, Pfizer, Inc. and Promius Pharma. A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.

SEGMENTATIONS IN THE REPORT:

By Forms:

  • Spray
  • Drops
  • Gel
  • Powder

By Container Type:

  • Pressurized Container
  • Non-Pressurized Container

By Therapeutic Applications:

  • Nasal Congestion
  • Rhinitis
  • Asthma
  • Others

By Geography:

  • North America (NA) - US, Canada & Rest of North America
  • Europe (EU) - UK, Germany, France & Rest of Europe
  • Asia Pacific (APAC) - China, Japan, India & Rest of APAC
  • Latin America (LA) - Brazil & Rest of Latin America
  • Middle East & Africa (MEA) - Middle East and Africa

Table of Contents

1. INTRODUCTION

  • Report Description
  • Research Scope
  • Research Methodology

2. EXECUTIVE SUMMARY

  • Market Highlight
  • Global Nasal Drug Delivery Technology Market: Snapshot

3. MARKET ANALYSIS

  • Introduction
  • Value Chain Analysis
  • Drivers
  • Restraints
  • Opportunities
  • Porter's Five Forces Analysis

4. NASAL DRUG DELIVERY TECHNOLOGY MARKET ANALYSIS BY FORMS

  • Market In Spray
  • Market In Drops
  • Market In Gel
  • Market In Powder

5. NASAL DRUG DELIVERY TECHNOLOGY MARKET ANALYSIS BY CONTAINER TYPE

  • Market In Pressurized Container
  • Market In Non-Pressurized Container

6. NASAL DRUG DELIVERY TECHNOLOGY MARKET ANALYSIS BY THERAPEUTIC APPLICATION

  • Market In Nasal Congestion
  • Market In Rhinitis
  • Market In Asthma
  • Market In Others

7. NASAL DRUG DELIVERY TECHNOLOGY MARKET ANALYSIS BY GEOGRAPHY

  • North America (NA)
  • North America Market Estimates
  • North America Market Estimates By Country
  • United States (U.S.)
  • Canada
  • Rest Of North America
  • Europe (EU)
  • Europe Market Estimates
  • Europe Market Estimates By Country
  • United Kingdom (UK)
  • Germany
  • France
  • Rest Of Europe
  • Asia Pacific (APAC)
  • Asia Pacific Market Estimates
  • Asia Pacific Market Estimates By Country
  • China
  • Japan
  • India
  • Rest Of Asia Pacific
  • Latin America (LA)
  • Latin America Market Estimates
  • Latin America Market Estimates By Country
  • Brazil
  • Rest Of Latin America
  • Middle East And Africa (MEA)
  • Middle East And Africa Market Estimates
  • Middle East And Africa Market Estimates By Country
  • Middle East
  • Africa

8. COMPETITIVE LANDSCAPE OF THE NASAL DRUG DELIVERY TECHNOLOGY COMPANIES

  • Market Competition
  • Partnerships/Collaborations/Agreements
  • Mergers And Acquisitions
  • New Product Launches
  • Other Developments

9. COMPANY PROFILES OF THE NASAL DRUG DELIVERY TECHNOLOGY INDUSTRY (Company Overview, Financial, Major Products & Recent Development)

  • AstraZeneca
  • B.F. Ascher & Company, Inc.
  • Becton, Dickson and Company
  • Cadila Pharmaceuticals
  • Douglas NZ
  • ENT Technologies Pty. Ltd.
  • GlaxoSmithkline plc.
  • NAVEH Pharma
  • OptiNose
  • Pendopharm
  • Pfizer, Inc.
  • Promius Pharma
  • Tentative TOC